Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$3,994,785
+$548,004 QoQ
Shares Held
15,875
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#1,455
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COURIER CAPITAL LLC holds $42,194,870 across 11 Drug Manufacturers - General names. ABBV ranks #5 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
64,486 | $16,377,509 | |
| 2 | MRK |
Merck & Co., Inc.
|
53,603 | $6,887,985 | |
| 3 | LLY |
ELI LILLY & Co
|
4,669 | $5,600,139 | |
| 4 | AMGN |
Amgen Inc
|
12,257 | $4,438,504 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
15,875 | $3,994,785 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
35,523 | $2,046,835 | |
| 7 | AZN |
Astrazeneca PLC
|
5,104 | $967,820 | |
| 8 | PFE |
Pfizer Inc
|
39,040 | $940,083 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,994,785 | 15,875 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $3,446,781 | 15,848 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $3,454,083 | 15,117 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $3,525,659 | 15,227 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $2,826,435 | 15,227 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $3,172,551 | 15,142 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $2,667,632 | 15,012 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $2,921,321 | 14,793 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $2,848,260 | 16,606 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $3,226,629 | 17,719 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $2,934,201 | 18,934 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $2,822,302 | 18,934 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $2,776,920 | 20,611 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $3,066,438 | 19,241 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $3,144,768 | 19,459 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $2,656,955 | 19,797 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $3,035,171 | 19,817 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $3,307,368 | 20,402 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $2,957,406 | 21,842 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $2,497,298 | 23,151 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $2,609,756 | 23,169 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $2,494,795 | 23,053 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $2,315,618 | 21,611 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,867,593 | 21,322 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,056,674 | 20,948 | Shares | Sole | 2020-07-06 | |
| 2020-03-31 | $1,453,781 | 19,081 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||